LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,750,166 | -2.7% | 1,872,118 | 0.0% | 0.93% | +42.9% |
| Q2 2023 | $129,232,306 | +35.7% | 1,872,118 | -5.2% | 0.65% | +5.3% |
| Q1 2023 | $95,264,927 | +79.9% | 1,975,631 | +86.2% | 0.62% | +46.7% |
| Q4 2022 | $52,958,481 | +23.1% | 1,060,867 | +0.6% | 0.42% | +54.0% |
| Q3 2022 | $43,004,000 | +36.2% | 1,054,017 | +83.6% | 0.27% | +48.1% |
| Q2 2022 | $31,575,000 | +131.8% | 574,087 | +53.1% | 0.18% | +203.3% |
| Q1 2022 | $13,623,000 | – | 374,870 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |